Rafael Góngora

TL;DR: This review presents the fundamental factors of nanoparticles and its microenvironment that must be considered to make an appropriate design for medical applications and the repercussions of the control, alter and modify these parameters in the biomedical applications.

TL;DR: All the common and synergy points between both areas are reviewed and described, and the recent approaches which show the progress from the bench to the beside to biomarkers developed in nanomedicine and onco-immunotherapy are described.

TL;DR: As this report shows, immunogenic cell death has been gaining importance in antitumor therapy and should be studied in depth as well as taking into account other applications that may arise from this immune phenomenon.

TL;DR: A new method based on an array technology that allows the deposition of hundreds to thousands of phages by micro-contact on a unique nitrocellulose surface that enables simultaneous affinity screening in a HT format of antibody-displaying phages is described.

TL;DR: In this paper, the authors used protein microarrays for parallel detection of multiple autoantibodies for increased specificity and sensitivity, which can be used for early detection of cancer and biomarkers of prognosis and treatment response.